Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
28
self-reported 11–50 band
Founded
Not recorded
Registry matches
1
ABR
Office countries
1
1 address
Funding rounds
None on record
Company type
Public Company
self-reported
Legal entity
1 brand → 1 possible registrationMatched by name against ABR, so this is a candidate list, not a confirmed identity. Confidence and match method are shown against every row.
ONCOSIL MEDICAL LTD
ABN89113824141
Legal entities
Show as table · OncoSil Medical: 1 registry entity
| ONCOSIL MEDICAL LTD | ABN 89113824141 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
OncoSil Medical is a global medical device company focused on Interventional Oncology. Our mission is to improve the outcomes by utilising the selected and targeted intratumoural placement of Phosphorous-32 (³²P) Microparticles in combination with chemotherapy.
OncoSil Medical’s lead product, OncoSil™, is a brachytherapy device which has received MDR approval, providing marketing authorisation in both the EU and the UK. The device is approved for use in New Zealand, Hong Kong, Switzerland, Turkey and Israel. OncoSil™ is designated as a breakthrough device in both Europe and the United States¹.
We believe in our technology and its ability to have a truly positive impact in Oncology.
OncoSil™ technology is not available in all geographies. If you are a healthcare professional, please refer to our website for information about our technology and indications.
Website link: oncosil.com
References: 1. US Food and Drug Administration (FDA) Breakthrough Device Designation. March 2020. The British Standards Institute (BSI) designated the device as a breakthrough product under MEDDEV. April 2020.
Specialties
All 1 specialty
- Interventional Oncology
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AULevel 5, 7 Eden Park Drive Macquarie Park; Sydney, NSW 2113Primary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entity operates under OncoSil Medical?
One New South Wales entity on the ABR: ONCOSIL MEDICAL LTD (ABN 89 113 824 141), medium confidence.
How many people work at OncoSil Medical?
28 counted staff profiles at January 2026, inside the self-reported 11–50 band.
Where does OncoSil Medical have offices?
One address on record, Australia only. Primary: Level 5, 7 Eden Park Drive Macquarie Park, Sydney, NSW 2113.
Has OncoSil Medical raised funding?
None linked to this brand.
What does OncoSil Medical list as its specialties?
One tag on the brand's own list, among them Interventional Oncology.
Which companies are listed alongside OncoSil Medical?
16 profiles list OncoSil Medical as a peer — 95th percentile in Medical Equipment Manufacturing. It lists ten peers of its own. Ultra Bionics and Tetratherix list it back.